🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories ◆ Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors ◆ Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows ◆ Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips ◆ Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare ◆ University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆ After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA ◆ The UK-India CETA: A Deep Dive into Bilateral Pharmaceutical Value Chains, API Trade, and Medicine Price Trajectories ◆ Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors ◆ Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows ◆ Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips ◆ Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare ◆ University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre ◆ Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026 ◆
Updated 24 Jul 2026 · ClinicalTrials.gov

Carcinoma, Renal Cell Trials in Ireland

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

0
Recruiting now
2
Active studies
Active Phase 3
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC · started 2021-04-14
📍 Dublin
NCT04736706 on ClinicalTrials.gov ↗
Active Phase 3
A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
Carcinoma, Renal Cell
Merck Sharp & Dohme LLC · started 2021-02-25
📍 Dublin
NCT04586231 on ClinicalTrials.gov ↗
No trials match your search.

Browse by location

Dublin · 80 Cork · 26 Galway · 16 Waterford · 9 Limerick · 6 Drogheda · 3 Elm Park · 2 Crumlin · 2 Sligo · 2 Rathgar · 1 Tallaght · 1 Wilton · 1

Browse by condition

Breast Cancer · 4 Multiple Myeloma · 3 Prostate Cancer · 3 Carcinoma, Renal Cell · 2 Chronic Lymphocytic Leukemia · 2 Obesity & Overweight · 2 Cerebral Palsy · 2 Hypertension · 2 Vascular Diseases · 2 Cardiovascular Diseases · 2 Ulcerative Colitis (UC) · 2
Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/condition/carcinoma-renal-cell (Accessed: 24 July 2026).

Embed this data ↗

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.